Top Markets
Coin of the day
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
Peringkat dalam Saham #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Harga Saham
$0.594
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$4.50M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-66.44%
Negara
US
Perdagangan Mustang Bio, Inc. (MBIO)

Kategori

Riwayat pemecahan saham untuk Mustang Bio, Inc. (MBIO)
Saham Mustang Bio, Inc. (simbol: MBIO) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 16, 2026.
Satu lembar saham MBIO yang dibeli sebelum Aug 16, 2026 sekarang setara dengan 0 lembar saham MBIO.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE